Carla Lopes

Has grant

Country flagPortugal

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

iPS cells-derived exosomes - impact on mitochondrial (dys)function in Huntington's disease and potential nanodelivery system for microRNA-based therapeutics

Open Date: 2018-01-01

Close Date: 2021-01-01

Grant: Close

ISSCR Travel Award

Open Date: 2017-06-01

Close Date: 2017-06-01

Grant: Close

Exploring the role of pridopidine on mitochondrial function and dynamics in Huntington’s disease models

Open Date: 2016-01-01

Close Date: 2018-01-01

Grant: Close

Creation and characterization of neural cells derived from pre-symptomatic and symptomatic Huntington´s disease patient-specific induced pluripotent stem cells

Open Date: 2015-12-01

Close Date:

Grant: Close

Creation and characterization of neural cells derived from pre-symptomatic and symptomatic Huntington´s disease patient-specific induced pluripotent stem cells

Open Date: 2015-12-01

Close Date: 2017-11-01

Articles (8)

Year:

2022

Mitochondrial and autophagy dysfunction are mechanisms proposed to be involved in the pathogenesis of several neurodegenerative diseases. Huntington's disease (HD) is a progressive neurodegenerative disorder associated with mutant Huntingtin‐induced abnormalities in neuronal mitochondrial dynamics and quality control. Former studies suggest that the removal of defective mitochondria may be compromised in HD. Mitochondrial quality control (MQC) is a complex, well‐orchestrated pathway that can be compromised through mitophagy dysregulation or impairment in the mitochondria‐lysosomal axis. Another mitochondrial stress response is the generation of mitochondrial‐derived vesicles that fuse with the endolysosomal system and form multivesicular bodies that are extruded from cells as extracellular vesicles (EVs). In this work, we aimed to study the presence of mitochondrial components in human EVs and the relation to the dysfunction of both mitochondria and the autophagy pathway. We comprehensively characterized the mitochondrial and autophagy alterations in premanifest and manifest HD carriers and performed a proteomic and genomic EVs profile. We observed that manifest HD patients exhibit mitochondrial and autophagy impairment associated with enhanced EVs release. Furthermore, we detected mitochondrial DNA and proteins in EVs released by HD cells and in neuronal‐derived EVs including VDAC‐1 and alpha and beta subunits of ATP synthase F1. HD‐extracellular vesicles transport higher levels of mitochondrial genetic material in manifest HD patients, suggesting an alternative pathway for the secretion of reactive mitochondrial components. This study provides a novel framework connecting EVs enhanced release of mitochondrial components to mitochondrial and lysosomal dysfunction in HD.

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Flaviano Giorgini

University of Leicester

UNITED KINGDOM
View details

Ana Cristina Rego

Associate Professor with 'Agregação'

Faculty of Medicine, University of Coimbra

PORTUGAL
View details

Maria Ankarcrona

Karolinska University Hospital

SWEDEN
View details

Luana Naia

Karolinska Institutet

SWEDEN
View details

Cristina Januário

University of Coimbra

PORTUGAL
View details

Jorge Valero

Associate Professor

Universidad de Salamanca

SPAIN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.